Prior to this week, Theator Inc. had only a single patent in the AI Biotech/Diagnostic Sector. However, this past week, the company had 7 fresh applications publish simultaneously. Theator is a biotech startup that very specifically focuses on creating surgical intelligence technologies. The company’s website describes their technology as the “next generation of AI in surgery – built by surgeons for surgeons, and designed to raise their expertise to the highest possible level.” 

Theator’s primary product is a surgical intelligence platform that allows a surgeon to watch detailed, pre-recored footage of operative procedures to prepare for upcoming surgeries, as well as use their own recorded surgical footage to analyze and reflect on their own previous work. The idea is that by watching both successful and unsuccessful footage from previous procedures, the doctors can add another step of preparation into their pre-surgery routine, as well as determine what wrong during an unsuccessful procedure.

The surgical intelligence platform is more than just video recorded footage. Using AI, the software performs annotations and smart filtering of the footage from the procedure. This allows doctors to skip through the footage to find relevant parts of the procedure to watch. Additionally, since the software is annotating and tagging the footage, it can provide an analytical breakdown of time spent at each step to improve surgical performance. The motivation behind this software is to ensure that surgeons are able to continuously improve their ability for as long as they are a surgeon. All 7 of Theator’s recent applications teach particular aspects of this software. Make sure to subscribe to the Magic Number® AI Biotech/Diagnostic Patent Forecast® to follow Theator’s progression and stay up to date with the most recent patent activity across the sector!